Serum deoxythymidine kinase correlates with peripheral lymphocyte thymidine uptake in chronic lymphocytic leukemia

The serum thymidine kinase (S‐TK) and proliferative activity of the leukemic cells were determined in 27 untreated patients with chronic lymphocytic leukemia (CLL). A significant positive correlation between S‐TK and proliferation expressed as a proliferative index (PI) was found (r = 0.70, p < 0.001). Additionally, PI (r = 0.59, p < 0.01) and S‐TK (r = 0.47, p < 0.05) correlated to peripheral blood lymphocyte count. When different variables and combinations of variables were studied in order to define their capacity for discriminating between progressive and indolent CLL, S‐TK activity and PI proved to be powerful indications. In longitudinal studies, both S‐TK and PI paralleled disease activity. A model where a combination of S‐TK and PI gives information of the degree of localized disease is proposed.

[1]  B. Simonsson,et al.  Evaluation of serum deoxythymidine kinase as a marker in multiple myeloma , 1985, British journal of haematology.

[2]  H. Hagberg,et al.  Serum thymidine kinase in vitamin B12 deficiency. , 2009, Scandinavian journal of haematology.

[3]  B Simonsson,et al.  Serum deoxythymidine kinase gives prognostic information in chronic lymphocytic leukemia , 1984, Cancer.

[4]  H. Hagberg,et al.  Serum thymidine kinase in acute leukaemia. , 1984, British Journal of Cancer.

[5]  U. Pettersson,et al.  Application of an in vitro assay for serum thymidine kinase: Results on viral disease and malignancies in humans , 1984, International journal of cancer.

[6]  H. Hagberg,et al.  The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma. , 1983, British Journal of Cancer.

[7]  E. Olding-Stenkvist,et al.  Rapid diagnosis of varicella-zoster virus infection by detection of viral deoxythymidine kinase in serum and vesicle fluid , 1983, Journal of clinical microbiology.

[8]  M. Van der Weyden,et al.  THYMIDINE KINASE ISOENZYMES IN CHRONIC LYMPHOCYTIC LEUKAEMIA , 1981, British journal of haematology.

[9]  K. Nilsson,et al.  3H-thymidine uptake in chronic lymphocytic leukaemia cells. , 2009, Scandinavian journal of haematology.

[10]  J. Sokal,et al.  In vitro leukocyte thymidine uptake and prognosis in chronic lymphocytic leukemia. , 1979, The American journal of medicine.

[11]  S. Kit Viral-associated and induced enzymes. , 1979, Pharmacology & therapeutics. Part B: General & systematic pharmacology.

[12]  L. Terenius,et al.  Biochemical characteristics of chronic lymphocytic leukaemia. Glucocorticoid receptors, B and T lymphocyte surface markers, concanavalin A-induced agglutination and thymidine incorporation. , 2009, Scandinavian journal of haematology.

[13]  L. Bello,et al.  Regulation of thymidine kinase synthesis in human cells. , 1974, Experimental cell research.

[14]  W. Knospe,et al.  Bi‐weekly chlorambucil treatment of chronic lymphocytic leukemia , 1974 .

[15]  V. Devita,et al.  Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone. , 1972, Annals of internal medicine.

[16]  J. Ambrus,et al.  Comparative study of the thymidine kinase and thymidylate kinase activities and of the feedbach inhibition of thymidine kinase in normal and neoplastic human tissue. , 1968, Cancer research.

[17]  A. Bøyum,et al.  Separation of leukocytes from blood and bone marrow. Introduction. , 1968 .